Good morning everyone, Our new NASDAQ profile has a tiny float, recently reported increasing sales/revenues and turned a lot of heads at the International Consumer Electronics Show (CES) in Las Vegas. Oh yeah, did I mention it's very close to 52 week lows and is showing a chart reversal now? I am talking about- NeuroMetrix Inc. (NASDAQ: NURO) Share structure and highlights Current PPS- $1.64/share 52 week range- $1.35 - $7.96/share Shares outstanding- 3.45M Shares in the float- 3.02M Held by insiders and institutions- 7.74% Revenue (TTM)- $5.97M Gross profit- $2.94M Shares short a/o Dec. 15th, 2015- 118K Recent press reports increasing sales/revenues- NeuroMetrix Reports preliminary financial highlights for 2015 http://finance.yahoo.com/news/neurometrix-announces-fda-510-k-180000127.html This past week, CES attracted about 170,000 people to Las Vegas to witness the newest and the most exciting consumer products in the technology industry. More than 3,800 companies showed off their various technologies across more than 2.47 million square feet of exhibit space. That's a lot of tech (and a lot of walking). But amid the crowded chaos, a number of products stood out from the crowd. One of the most interesting FDA approved devices was the Quell ( http://finance.yahoo.com/news/neurometrix-announces-fda-510-k-180000127.html ), by NeuroMetrix Inc. (NASDAQ: NURO). NeuroMetrix (NASDAQ: NURO) showed off a wearable band that aims to eliminate the need for Advil or pain medication. The wearable, is worn around the calf and sends messages to the brain to minimize pain. The wearable can be controlled by a smartphone app, which also tracks sleep data to better understand how someone's pain is affecting their sleep. The newest version of Quell will be available in March, and the current starter kit costs $249. We will be back with more on (NASDAQ: NURO) The Team |
|